The atypical antipsychotic agents, which are commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance, increasing the risk for Type 2 diabetes and heart disease later in life, according to a presentation at the annual meeting of the American Academy of Child and Adolescent Psychiatry.

In the current study, an American team evaluated 11 children, some overweight and others obese, who gained significant amounts of weight (typically, a 10 percent weight increase) while taking the new-generation, or atypical, antipsychotic drugs olanzapine, quetiapine, or risperidone. Considerable weight gain is a common side effect of atypical antipsychotic medications, and is also one of the many factors that can contribute to insulin resistance.

All six children on moderate or high doses of one of these drugs, and three of five children on low doses, had evidence of insulin resistance, a condition in which the body cannot properly use the insulin it produces. This evidence included hypertension, high levels of triglycerides, low levels of high density lipoprotein cholesterol, and proteinuria.

“The insulin resistance seen in these children was greater than what would be expected from weight gain alone, suggesting there is a factor distinct from excess weight that directly induces insulin resistance,” said the study’s lead author, Mark A. Riddle, MD.

“Treatments are always a matter of risk and benefit balance. Clearly these drugs are an important treatment option. But diabetes and heart disease are serious health issues, so it’s important to further investigate this apparent relationship between atypical antipsychotics and insulin production and consumption,” Riddle added. “We may need to reexamine how we are prescribing these drugs to see if dosage changes can be made to ensure children will continue to receive the benefits of these medications while not putting them at risk for developing other health problems in the future.”

If the study’s findings are confirmed by larger follow-up studies, Riddle says he would expect monitoring of metabolic side effects to become standard practice among clinicians prescribing atypical antipsychotics to children.

Insulin resistance occurs when muscle, fat, and liver cells do not properly use insulin, the hormone produced by the pancreas that helps cells absorb glucose and provides a source of energy to the body. The pancreas tries to keep up with the demand for insulin by producing more. Eventually, the pancreas cannot keep up with the body's need for insulin, and excess glucose builds up in the bloodstream. Excess weight, lack of exercise, and a family history of diabetes all contribute to insulin resistance. The condition is associated with an increased risk of developing Type 2 diabetes, heart disease, and stroke.